Its as if the character of the company has changed.
Previous to this CR, it seemed like a tight ship, keeping costs down, low spends, plans mapped out and accunted for.
Now we have a CR blindsighting all us retail shareholders, no communication on why apart from this prospectus (of which Murray Meds was covered), salaries going up substantially, including an easy 200k salary for Nan after just paying her 7.5 mill for the company we bought, and ontop of that budgeting spending a million on European staff when we havent even got updates of stage 1 being completed. And as jimbo says, you can imagine how many flights back and forth under the guise of business meetings now.
How about getting operations running like a well oiled machine in Australia first, communicating with shareholders exactly whats happening (where are we at, whats planned with crops) before starting to spend money we didnt need to, what happened to growing organically as Alex said in one of his inerviews, this company just changed up quick and now a lot of high paid execs on board and what have we got to show for it?
ECS Price at posting:
5.4¢ Sentiment: Buy Disclosure: Held
